A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma-Reference-Cited by-同舟云学术

A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma

Published:2021-09-23 Issue:12 Volume:60 Page:1557-1564
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

van Meekeren Milan¹^ORCID,Bovee Judith V. M. G.²^ORCID,van Coevorden Frits³,van Houdt Winan³,Schrage Yvonne³,Koenen Anne Miek⁴,Miah Aisha B.⁵,Zaidi Shane⁵,Hayes Andrew J.⁶,Thway Khin⁷,Krol Stijn⁸,Fiocco Marta⁹,Gelderblom Hans¹^ORCID,Steeghs Neeltje⁴,Haas Rick L.⁸¹⁰^ORCID

Affiliation:

1. Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands

2. Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands

3. Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

4. Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands

5. Department of Clinical Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom

6. Department of Surgery, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom

7. Department of Pathology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom

8. Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands

9. Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands

10. Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Funder

Novartis

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1971294

Reference37 articles.

1. O'Sullivan B, Davis AM, Turcotte R, et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet. 2002;359(9325):2235–2241.

2. Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma

3. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathologic complete response in patients with localized soft tissue sarcoma treated with neoadjuvant therapy and its correlation with clinical outcomes: A systematic review;Cancer Treatment Reviews;2024-11

2. Unraveling the Myth of Radiation Resistance in Soft Tissue Sarcomas;Seminars in Radiation Oncology;2024-04

3. Elderberry interaction with pazopanib in a patient with soft‑tissue sarcoma: A case report and literature review;Molecular and Clinical Oncology;2024-03-20

4. Neoadjuvant radiotherapy and wound complication: literature review and review of single surgeon series of myxoid liposarcoma treated with neoadjuvant radiotherapy followed by surgery;Journal of Radiotherapy in Practice;2024

5. Current stand on systemic therapy in localized soft tissue sarcomas: a clinician's perspective;Future Oncology;2023-10